Results 91 to 100 of about 57,725 (152)

[Characteristic of the active substance of the Saccharomyces cerevisiae preparation having radioprotective properties]. [PDF]

Vavilovskii Zhurnal Genet Selektsii, 2020
Ritter GS, Nikolin VP, Popova NA, Proskurina AS, Kisaretova PE, Taranov OS, Dubatolova TD, E V Dolgova EV, Potter EA, Kirikovich SS, Efremov YR, Bayborodin SI, Romanenko MV, Meschaninova MI, Venyaminova AG, Kolchanov NA, Bogachev SS.   +16 more
europepmc   +1 more source

[Meta-analysis of experimental studies of the effect of melatonin monotherapy on the levels of thyroid hormones and glucocorticoids in rats kept under standard condition]. [PDF]

Probl Endokrinol (Mosk)
Kuzmenko NV, Tsyrlin VA, Pliss MG.
europepmc   +1 more source

[Immunometabolic disorders in type 2 diabetes mellitus mediated by NLRP3 inflammasome activation and methods of pharmacological correction thereof]. [PDF]

Probl Endokrinol (Mosk)
Cheplyaeva NI, Babkov DA, Lukyanov AV, Danilov RD, Spasov AA.   +4 more
europepmc   +1 more source

[Pathogenetically justified use in real clinical practice of vaginal estriol 0.5 mg in women of different ages]. [PDF]

Probl Endokrinol (Mosk)
Andreeva EN, Sheremetyeva EV, Vesnina AF, Uzhegova ZA.   +3 more
europepmc   +1 more source

[Primary Generalized Glucocorticoid Resistance: a case report]. [PDF]

Probl Endokrinol (Mosk)
Larina II, Makazan NV, Ivashchenko KV, Platonova NM, Orlova EM, Kareva MA, Sozaeva LS, Yukina MY, Tulpakov AN, Dukhanin AS, Shimanovskii NL, Troshina EA.   +11 more
europepmc   +1 more source

[Non-classical hormones from the fibroblast growth factor family]. [PDF]

Probl Endokrinol (Mosk)
Gronskaia SA, Rusyaeva NV, Belaya ZE, Melnichenko GA.   +3 more
europepmc   +1 more source

[The history of the pharmacotherapy of obesity]. [PDF]

Probl Endokrinol (Mosk)
Berkovskaya MA, Gurova OY, Surkova EV, Fadeev VV.   +3 more
europepmc   +1 more source

Политическая экономия – ядро экономико-теоретического знания [PDF]

, 2018
Костюкович, Н.В.
core  

[Highly selective sodium-glucose co-transporter type 2 inhibitor empagliflozin as means of brain protection in conditions of chronic brain dyscirculation]. [PDF]

Probl Endokrinol (Mosk)
Simanenkova AV, Fuks OS, Timkina NV, Sufieva DA, Kirik OV, Korzhevskii DE, Vlasov TD, Karonova TL.   +7 more
europepmc   +1 more source

Liberties of the genome: insertions of mitochondrial DNA fragments into nuclear genome. [PDF]

Vavilovskii Zhurnal Genet Selektsii
Golubenko MV, Puzyrev VP.
europepmc   +1 more source